37th week of 2018 patent applcation highlights part 10 |
Patent application number | Title | Published |
20180256599 | OLIGOMER-CORTICOSTEROID CONJUGATES | 2018-09-13 |
20180256600 | METHODS OF TREATING CANCER | 2018-09-13 |
20180256601 | URSODEOXYCHOLIC ACID AND BRAIN DISORDERS | 2018-09-13 |
20180256602 | METHODS OF PROMOTING HEPATIC REGENERATION | 2018-09-13 |
20180256603 | COMPOSITIONS COMPRISING TRITERPENOIDS | 2018-09-13 |
20180256604 | USE OF GLUCOCORTICOID RECEPTOR MODULATORS IN THE TREATMENT OF CATECHOLAMINE-SECRETING TUMORS | 2018-09-13 |
20180256605 | SLOW RELEASE OXYSTEROLS AND METHODS OF USE | 2018-09-13 |
20180256606 | MULTILAYER DOSAGE FORMS, WHICH CONTAIN ACTIVE SUBSTANCES AND WHICH COMPRISE A NEUTRAL CORE, AND AN INNER AND OUTER COATING CONSISTING OF METHACRYLATE COPOLYMERS AND METHACRYLATE MONOMERS | 2018-09-13 |
20180256607 | SOLID DRUG DELIVERY APPARATUS, FORMULATIONS AND METHODS OF USE | 2018-09-13 |
20180256608 | Lyophilized Cyclophosphamide Composition and Methods of Preparation Thereof | 2018-09-13 |
20180256609 | Lyophilized Cyclophosphamide Composition and Methods of Preparation Thereof | 2018-09-13 |
20180256610 | Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | 2018-09-13 |
20180256611 | BISPHOSPHONATES FOR INCREASING THE TYPE 2 CHARACTER OF A MODIC CHANGE | 2018-09-13 |
20180256612 | Composition Comprising Ketone Body and Nicotinamide Adenine Dinucleotide Modulator and Methyl Donor | 2018-09-13 |
20180256613 | NANOEMULSION SYNTHETIC RED BLOOD CELLS HAVING SEQUENTIALLY FORMED CALCIUM PHOSPHATE COATING AND PREPARATION METHOD THEREOF | 2018-09-13 |
20180256614 | COMPOSITIONS AND METHODS OF TREATING OF BACTERIAL INFECTIONS WITH BETA-LACTAMASE INHIBITORS | 2018-09-13 |
20180256615 | COMPOSITION FOR MAINTAINING LACTOBACILLUS DOMINANCE | 2018-09-13 |
20180256616 | Compounds, Compositions and Methods for Prevention or Treatment of Liver and Lipid-Related Conditions | 2018-09-13 |
20180256617 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | 2018-09-13 |
20180256618 | ANTIVIRAL SUPPLEMENT FORMULATIONS | 2018-09-13 |
20180256619 | METHODS OF USE FOR OENOTHEIN A AND B FROM EPILOBIUM SPECIES | 2018-09-13 |
20180256620 | EDIBLE COMPOSITION | 2018-09-13 |
20180256621 | Composition and Methods Thereof | 2018-09-13 |
20180256622 | INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF | 2018-09-13 |
20180256623 | COMPOSITIONS AND METHOD FOR REGULATING ADIPOSE TISSUE LIPOLYSIS, INSULIN-RESISTANCE, AND HYPERGLYCEMIA | 2018-09-13 |
20180256624 | METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS | 2018-09-13 |
20180256625 | METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE | 2018-09-13 |
20180256626 | Composition of Novel Carbohydrate Drug for Treatment of Human Diseases | 2018-09-13 |
20180256627 | COSMETIC COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES DERIVED FROM MICROBIAL MATS, AND METHODS OF USE THEREOF | 2018-09-13 |
20180256628 | METHODS FOR THERAPEUTIC ADMINISTRATION OF MESSENGER RIBONUCLEIC ACID DRUGS | 2018-09-13 |
20180256629 | METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION | 2018-09-13 |
20180256630 | USE OF NUCLEIC ACID-POLYSACCHARIDE COMPLEXES HAVING IMMUNOPOTENTIATING ACTIVITY AS ANTI-TUMOR DRUG | 2018-09-13 |
20180256631 | Binding of Galectin-3 By Low Molecular Weight Pectin | 2018-09-13 |
20180256632 | Binding of Galectin-3 By Low Molecular Weight Pectin | 2018-09-13 |
20180256633 | LONG CHAIN INULIN FOR STIMULATING AN IMMUNE RESPONSE | 2018-09-13 |
20180256634 | NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES | 2018-09-13 |
20180256635 | LAXATIVE FORMULATIONS AND MANUFACTURE | 2018-09-13 |
20180256636 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | 2018-09-13 |
20180256637 | INTRADIALYTIC USE OF SODIUM NITRITE | 2018-09-13 |
20180256638 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2018-09-13 |
20180256639 | INTRADIALYTIC USE OF SODIUM THIOSULFATE | 2018-09-13 |
20180256640 | MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF | 2018-09-13 |
20180256641 | POWDER COMPOSITIONS FOR GENERATING CROSS-LINKED PROTEIN FOAMS AND METHODS OF USING THEREOF | 2018-09-13 |
20180256642 | BIOMATERIALS DERIVED FROM TISSUE EXTRACELLULAR MATRIX | 2018-09-13 |
20180256643 | METHOD OF EX VIVO CELLULAR GROWTH | 2018-09-13 |
20180256644 | TUNABLE VARIANT IMMUNOGLOBULIN SUPERFAMILY DOMAINS AND ENGINEERED CELL THERAPY | 2018-09-13 |
20180256645 | CXCR6-TRANSDUCED T CELLS FOR TARGETED TUMOR THERAPY | 2018-09-13 |
20180256646 | COMPOSITIONS AND METHODS FOR MODULATING TOLL LIKE RECEPTOR SIGNAL | 2018-09-13 |
20180256647 | Innervation Of Engineered Structures | 2018-09-13 |
20180256648 | ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY | 2018-09-13 |
20180256649 | STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION | 2018-09-13 |
20180256650 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | 2018-09-13 |
20180256651 | COMPOSITION HAVING LACTOBACILLUS PARACASEI STRAIN GMNL-653 FOR TREATING PSORIASIS | 2018-09-13 |
20180256652 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | 2018-09-13 |
20180256653 | METHODS AND COMPOSITIONS FOR REDUCING VANCOMYCIN-RESISTANT ENTEROCOCCI INFECTION OR COLONIZATION | 2018-09-13 |
20180256654 | USE OF LACTOBACILLUS PARACASEI STRAIN GMNL-653 TO PREPARE COMPOSITION FOR RESISTING BONE LOSS | 2018-09-13 |
20180256655 | Newcastle Disease Viruses and Uses Thereof | 2018-09-13 |
20180256656 | USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT | 2018-09-13 |
20180256657 | Natural method for eliminating HIV to be employed by type 1 and 2 HIV sufferers | 2018-09-13 |
20180256658 | COMPOSITION CONTAINING MIXED EXTRACT OF MULBERRY AND PORIA COCOS BARK FOR PREVENTING, IMPROVING OR TREATING NEURODEGENERATIVE DISORDERS | 2018-09-13 |
20180256659 | METHOD OF USING A MANGIFERA INDICA COMPOSITION IN THE TREATMENT OF OBESITY | 2018-09-13 |
20180256660 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | 2018-09-13 |
20180256661 | Pharmaceutical Composition for Prevention and Treatment of Flatulence and Diarrhea in Rabbit and Formula and Application Thereof | 2018-09-13 |
20180256662 | PRODUCT AND METHOD OF DEPLOYING KALE DERIVATIVES FOR ANTI-CANCER EFFECTS | 2018-09-13 |
20180256664 | COMPOSITION FOR PREVENTING OR TREATING STROKE OR DEGENERATIVE BRAIN DISEASE | 2018-09-13 |
20180256665 | MULATEIRO-DERIVED COMPOSITIONS AND USE THEREOF FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH | 2018-09-13 |
20180256666 | FRUIT EXTRACTS | 2018-09-13 |
20180256667 | COMBINATION AND/OR COMPOSITION COMPRISING BACILLUS, AND YUCCA, QUILLAJA, OR BOTH AND A METHOD FOR USING AND MAKING | 2018-09-13 |
20180256668 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OR REMISSION IN ELDERLY OR TERMINAL CANCER PATIENT | 2018-09-13 |
20180256669 | Treating Renal and Liver Dysfunction with TLR4 Antagonists | 2018-09-13 |
20180256670 | TREATMENT OF ENDOMETRIOSIS, ANGIOGENESIS AND/OR ENDOMETRIAL LESION GROWTH | 2018-09-13 |
20180256671 | Hard Capsule Shell Compositions for the Treatment of Irritable Bowel Syndrome | 2018-09-13 |
20180256672 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | 2018-09-13 |
20180256673 | METHODS FOR TREATING FUNGAL INFECTIONS | 2018-09-13 |
20180256674 | Combinational Therapy for Synergistic Inhibition of Gram-Positive and Gram-Negative Bacteria | 2018-09-13 |
20180256675 | COMPOSITIONS AND METHODS FOR TREATING NAIL INFECTIONS | 2018-09-13 |
20180256676 | METHODS AND DEVICES FOR BONE INFECTION TREATMENT SELECTION | 2018-09-13 |
20180256677 | PHARMACEUTICAL COMPOSITION COMPRISING GINSENG EXTRACTS FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES | 2018-09-13 |
20180256678 | ANTI-TUMOR THERAPY | 2018-09-13 |
20180256679 | Soluble Mediator | 2018-09-13 |
20180256680 | A H3T3A MUTANT PROTEIN EFFICIENTLY REDUCES H3T3P AND CAUSES INCREASED CELL DEATH OF RAPIDLY DIVIDING CELLS | 2018-09-13 |
20180256681 | PROTECTION AGAINST AND TREATMENT OF IONIZING RADIATION | 2018-09-13 |
20180256682 | SRPX FOR TREATMENT OF CANCER | 2018-09-13 |
20180256683 | Compositions and Methods for Treating Heart Failure | 2018-09-13 |
20180256684 | MODULATION OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR ACTIVITY FOR TYMPANIC MEMBRANE HEALING | 2018-09-13 |
20180256685 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORNEAL HAZE AND SCARRING | 2018-09-13 |
20180256686 | Compositions and Methods for Treating Ischemia | 2018-09-13 |
20180256687 | MODULATORS OF PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF | 2018-09-13 |
20180256688 | METHODS AND COMPOSITIONS FOR IMPROVED COGNITION | 2018-09-13 |
20180256689 | METHODS OF TREATING ABNORMALITIES OF THE FIRST METATARSOPHALANGEAL JOINT OF THE FOOT | 2018-09-13 |
20180256690 | PROTECTION AND SEALING OF THE OCULAR SURFACE BARRIER BY CLUSTERIN | 2018-09-13 |
20180256691 | UNIVERSAL CANCER VACCINE | 2018-09-13 |
20180256692 | VACCINE THERAPY FOR TREATMENT OF ENDOMETRIAL AND OVARIAN CANCER | 2018-09-13 |
20180256693 | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers | 2018-09-13 |
20180256694 | COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) | 2018-09-13 |
20180256695 | COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT | 2018-09-13 |
20180256696 | COXIELLA BURNETII ANTIGENS | 2018-09-13 |
20180256697 | NON-TOXIGENIC CLOSTRIDIUM DIFFICILE SPORES FOR USE IN ORAL VACCINATION | 2018-09-13 |
20180256698 | PROLINE-RICH PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE | 2018-09-13 |
20180256699 | BORDETELLA ADENYLATE CYCLASE TOXIN VACCINES AND NEUTRALIZING ANTIBODIES | 2018-09-13 |